Study details
Enrolling now
A Study to Evaluate the Impact of a Magnolia Officinalis Dietary Supplement on Immune Biomarkers in Subjects With Psoriasis
Sirt3 LLC
NCT IDNCT07471048ClinicalTrials.gov data as of Apr 2026
Ages
18+
Locations
1 site in NJ
What this study is about
This study is testing Oral supplement containing 200mg Magnolia officinalis bark extract in people with psoriasis.
Simplified from trial records by PatientMatch.
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Oral
How treatment is administered
Treatment Assignment
Standard assignment
Assignment is predetermined by the study protocol.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Drug classes
dietary supplement
Drug routes
oral
Endpoints
Secondary: Quality of life assessment, Self reported psoriasis symptoms
Body systems
Dermatology